wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36326096-03B04C75-1036-4AF2-92E5-4D176BE5E45D
Q36326096-03B04C75-1036-4AF2-92E5-4D176BE5E45D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36326096-03B04C75-1036-4AF2-92E5-4D176BE5E45D
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada
P2860
Q36326096-03B04C75-1036-4AF2-92E5-4D176BE5E45D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36326096-03B04C75-1036-4AF2-92E5-4D176BE5E45D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0ebf6495fc2ef65de30b7d7d361727e5af16a12
P2860
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.